Industry feels that as the market for biologic drugs mature, rising affordability is likely to enhance patient access
from Latest News https://ift.tt/2INOdkB
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd
Home
Business
Business News
Business Standard
Latest News
Growing competition leads to price erosion in biosimilars in India
Monday, October 8, 2018
Related Posts:
China Evergrande makes onshore coupon payment: ReportThe liquidity crisis at Evergrande, which has $300 billion in debt and… Read More
Smartphone producer Foxconn announces electric car ventureThe Taiwanese company that manufactures smartphones for Apple Inc. and… Read More
Babul Supriyo formally resigns as Bharatiya Janata Party Lok Sabha MPFormer Union Minister Babul Supriyo on Tuesday formally submitted his … Read More
DATA STORY: India logs 13,058 cases; 8,741,160 doses administered in 24 hrsIndia has so far administered 986,769,411 vaccine doses. That is 2894.… Read More
0 comments: